OKYO Pharma director Brancaccio raises stake to 35,201 shares after $1.48 purchase
OKYO•Director increases holding after Nasdaq purchase
OKYO Pharma non-executive director John Brancaccio bought 5,000 ordinary shares on Nasdaq at $1.48 each.
The purchase lifted his total holding to 35,201 shares.
